Millipore Sigma Vibrant Logo

SCM121 OsteoMAX-XF™ Differentiation Medium

Defined Xeno-Free osteogenesis differentiation medium that is specially formulated to readily differentiate human mesenchymal stem cells (MSCs) into mature osteocytes as assessed by alizarin red & alkaline phosphatase staining.

OsteoMAX-XF™ Differentiation Medium MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.
Key Applications: Cell Culture, Stem Cell Culture
View Products on Sigmaaldrich.com
SCM121
100ml/kit  
正在检索价格......
无法检索价格。
最小订购数量为倍数
Maximum Quantity is
以订单确认为准 更多信息
您节约了 ()。
 
—
Request Pricing
—
目前缺货 目前缺货
有货 
停产
少量现货
供货情况有待确认
    其余：另行通知
      其余：另行通知
      另行通知
      联系客户服务
      Contact Customer Service

       

      联系客户服务

      概述

      Replacement Information

      重要规格表

      Key Applications
      CULT, Cult
      Description
      Catalogue NumberSCM121
      Trade Name
      • OsteoMAX-XF
      DescriptionOsteoMAX-XF™ Differentiation Medium
      Alternate Names
      • Osteogenesis media
      • Osteocyte differentiation media
      Background InformationBone undergoes a continual remodeling process that requires the coordinated activity of two cell types. Osteoclasts break down the bone matrix while osteoblasts deposit collagen, calcium, and phosphorous and other minerals to form new bone. The balance between the activity of osteoclasts and osteoblasts determines the mass and density of the bone. Many diseases of bone including osteoporosis, a common age-related phenomenon in post-menopausal women in which the bone mass has been greatly reduced, and osteogenesis imperfecta, also known as brittle-bone disease, are likely caused by the misregulation of osteoblasts and osteoclasts. Understanding the molecular mechanisms that underlie osteogenesis, the process by which new bone is formed is thus of critical importance.

      Mesenchymal stem cells (MSC) are defined as a self-renewing population of adherent, multipotent progenitor cells with the capacity to differentiate into several mesenchymal cell lineages. MSC have been isolated from adult bone marrow, adipose tissue, and umbilical cord blood and can be generated in vitro from embryonic and induced pluripotent stem cells. In defined in vitro assays, MSC have been shown to readily differentiate into lineage-specific cells that form bone, cartilage, fat, tendon, and muscle tissues.

      EMD Millipore’s OsteoMAX-XF™ Differentiation Medium is specially formulated to readily differentiate human mesenchymal stem cells into the osteogenic lineage (osteocytes) as assessed by alizarin red and alkaline phosphatase staining. This proprietary formulation was developed using Plasticell’s CombiCultTM, a patented, bead-based, combinatorial technology specially developed for discovery of novel stem cell differentiation protocols.

      Features and Benefits
      - Serum-free, xeno-free, defined medium formulation
      - Rapid, robust, and highly efficient mineralization and bone nodule formation in standard tissue culture system by as early as 7 days of differentiation.

      Using EMD Millipore's OsteoMAX-XF™ Differentiation Media, we typically obtain 80% mature osteocytes from bone marrow derived mesenchymal stem cells. Efficiency of osteogenic differentiation may vary, depending upon the source and quality of the mesenchymal stem cells and if variations to the protocol are introduced.
      References
      Product Information
      Components
      • 1. OsteoMAX-XF™ Basal Medium (Part No. CS210596). One bottle containing 90 mL basal medium.
      • 2. OsteoMAX-XF™ Supplement (10X) (Part No. CS210597). One bottle containing 10 mL of 10X concentrated supplement.
      HS Code3002 15 90
      Quality LevelMQ100
      Applications
      ApplicationDefined Xeno-Free osteogenesis differentiation medium that is specially formulated to readily differentiate human mesenchymal stem cells (MSCs) into mature osteocytes as assessed by alizarin red & alkaline phosphatase staining.
      Key Applications
      • Cell Culture
      • Stem Cell Culture
      Biological Information
      Cross ReactivityNone
      Media FormLiquid
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsOsteoMAX-XF™ Basal Medium: (Part No. CS210596) should be stored at -20°C until ready to use. Use within four months from date of receipt. Upon thawing, the medium can be kept refrigerated at 2° to 8°C in the dark for up to 6 months.

      OsteoMAX-XF™ Supplement (10X): (Part No. CS210597) should be stored at -20°C until ready to use. Use within four months from date of receipt. Upon thawing, add the Supplement to the Basal Medium, mix thoroughly and filter sterilize using a 0.22 um stericup filter. The filtered supplemented complete media can be stored short term at 2 to 8°C in the dark and should be used within 7 days. For long term storage, aliquot the filtered supplemented complete media into appropriate working volumes and stored at -20°C. Avoid repeated freeze-thaw cycles as it will affect activity levels.
      Packaging Information
      Material Size100ml/kit
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      产品目录编号 GTIN
      SCM121 04053252847899